ArticleMMWR. Morbidity and mortality weekly report2018
Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016-June 2017.
Article in MMWR. Morbidity and mortality weekly report, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 96 citations in OpenAlex.
- Non-opioid psychiatric medications for chronic pain: systematic review and meta-analysis.Frontiers in pain research (Lausanne, Switzerland) · 2024Pooled it
- Multinational appraisal of the epidemiological distribution of opioid fatalities: a systematic review and meta-analysis.Frontiers in psychiatry · 2023Pooled it
- Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release.Journal of substance abuse treatment · 2022Trial
- Suzetrigine for Acute Pain in the Emergency Department: A First-in-Class NaV1.8 Blocker.Journal of the American College of Emergency Physicians open · 2026Article
- Article
- Acceptability and perceived feasibility of restroom motion sensors for overdose detection and response in public bathrooms: A cross-sectional study of businesses and community organizations.Drug and alcohol dependence · 2025Article
- Missouri naloxone distribution 2017-2023: Evaluation and implications of applying a naloxone saturation model.Journal of substance use and addiction treatment · 2025Article
- Using illicit drugs alone in Vancouver, Canada: a gender-based analysis.Substance abuse treatment, prevention, and policy · 2025Article
- An interrupted time series analysis of fentanyl, naloxone, and opioid-involved deaths in five counties in Eastern Missouri.Journal of substance use and addiction treatment · 2025Article
- Nonfatal pediatric fentanyl exposures reported to US poison centers, 2015-2023.The American journal of drug and alcohol abuse · 2025Article
- Risk of prolonged postoperative opioid use after elective shoulder replacement: a nationwide cohort study of 5,660 patients from the Danish Shoulder Arthroplasty Registry.Acta orthopaedica · 2024Article
- Epidemiological Aspects of Opioid Poisoning in Northern Iran: A Registry-Based Clinical Study.Health services insights · 2024Article
- A case study for local data surveillance in opioid overdose fatalities in Cuyahoga County, OH 2016-2020.Drug and alcohol dependence reports · 2023Article
- Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study.Harm reduction journal · 2023Article
- Non-medical prescription opioid use among high school students in 38 U.S. States.Addictive behaviors reports · 2023Article
- Surveillance for Violent Deaths - National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2020.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2023Article
- Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection.Addiction (Abingdon, England) · 2023Article
- Increased solitary drug use during COVID-19: An unintended consequence of social distancing.The International journal on drug policy · 2023Article
- Unsolicited reporting notifications (URNs) through Maryland's prescription drug monitoring program (PDMP): Characteristics of providers.Drug and alcohol dependence reports · 2022Article
- Substance use disorders and social determinants of health from electronic medical records obtained during Kentucky's "triple wave".Pharmacology, biochemistry, and behavior · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2016, 63,632 drug overdose deaths occurred in the United States, 42,249 (66.4%) of which involved opioids (1). The development of prevention programs are hampered by a lack of timely data on specific substances contributing to and circumstances associated with fatal overdoses. This report describes opioid overdose deaths (referred to as opioid deaths) for decedents testing positive for prescription opioids (e.g., oxycodone and hydrocodone), illicit opioids (e.g., heroin, illicitly manufactured fentanyl, and fentanyl analogs), or both prescription and illicit opioids, and describes circumstances surrounding the overdoses, in 11 states participating in CDC's Enhanced State Opioid Overdose Surveillance (ESOOS) program.* During July 2016-June 2017, among 11,884 opioid overdose deaths, 17.4% of decedents tested positive for prescription opioids only, 58.7% for illicit opioids only, and 18.5% for both prescription and illicit opioids (type of opioid could not be classified in 649 [5.5%] deaths). Approximately one in 10 decedents had been released from an institutional setting in the month preceding the fatal overdose. Bystanders were reportedly present in approximately 40% of deaths; however, naloxone was rarely administered by a layperson. Enhanced surveillance data from 11 states provided more complete information on the substances involved in and circumstances surrounding opioid overdose deaths. Consistent with other emerging evidence and recommendations,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.